Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968721 · ClinicalTrials.gov registry record
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 55
- Enrollment target
NCT00968721: Clinical Trial study, sponsored by Vanderbilt University.
NCT00968721 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00968721 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The primary purpose of this study is to pilot test an instrument that the investigators will develop to assess decision influences on inflammatory bowel disease patients' medication adherence decision-making. This pilot study will use an exploratory, descriptive cross-sectional survey approach to pilot test the instrument and answer the research questions. The main hypothesis is that patients at risk for intentionally modifying their prescribed medication regimen will differ on influences on decision-making, health status, and utilization of the IBD clinic services compared to those who are intentionally adherent and who continue adherence over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-12 |
Why NCT00968721 stopped before completion
NCT00968721 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00968721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00968721 about?
NCT00968721 is a clinical study titled "Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use". The primary purpose of this study is to pilot test an instrument that the investigators will develop to assess decision influences on inflammatory bowel disease patients' medication adherence decision-making. This pilot study will use an exploratory, descriptive cross-sectional survey approach to p...
What is the current status of trial NCT00968721?
This trial is currently terminated. The enrollment target is 55 participants. The study started on 2010-06. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00968721?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia